Annals of Colorectal Research

Published by: Kowsar

The Changing Face of Inflammatory Bowel Disease: Etiology, Physiopathology, Epidemiology

Giovanni Clemente Actis 1 , *
Author Information
1 Department of Gastro-Hepatology, Gradenigo Hospital, Ospedale Gradenigo, Italy
Article information
  • Annals of Colorectal Research: March 01, 2016, 4 (1); e32942
  • Published Online: January 1, 2016
  • Article Type: Review Article
  • Received: September 20, 2015
  • Accepted: September 29, 2015
  • DOI: 10.17795/acr-32942

To Cite: Clemente Actis G. The Changing Face of Inflammatory Bowel Disease: Etiology, Physiopathology, Epidemiology, Ann Colorectal Res. 2016 ; 4(1):e32942. doi: 10.17795/acr-32942.

Abstract
Copyright © 2016, Colorectal Research Center and Health Policy Research Center of Shiraz University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
References
  • 1. Heller F, Fuss IJ, Nieuwenhuis EE, Blumberg RS, Strober W. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity. 2002; 17(5): 629-38[PubMed]
  • 2. Thompson AI, Lees CW. Genetics of ulcerative colitis. Inflamm Bowel Dis. 2011; 17(3): 831-48[DOI][PubMed]
  • 3. Actis GC, Pellicano R, Fadda M, Rosina F. Antibiotics and non-steroidal anti-inflammatory drugs in outpatient practice: Indications and unwanted effects in a gastroenterological setting. Curr Drug Saf. 2014; 9(2): 133-7[PubMed]
  • 4. Samonis G, Maraki S, Anatoliotakis N, Anatoliotaki M, Apostolakou H, Margioris AN, et al. Effects of erythromycin, clarithromycin, roxithromycin and azithromycin on murine gut colonization by Candida albicans. Med Mycol. 2002; 40(2): 139-42[PubMed]
  • 5. Frank CF, Hostetter MK. Cleavage of E-cadherin: A mechanism for disruption of the intestinal epithelial barrier by Candida albicans. Transl Res. 2007; 149(4): 211-22[DOI][PubMed]
  • 6. Rosen MJ, Frey MR, Washington MK, Chaturvedi R, Kuhnhein LA, Matta P, et al. STAT6 activation in ulcerative colitis: A new target for prevention of IL-13-induced colon epithelial cell dysfunction. Inflamm Bowel Dis. 2011; 17(11): 2224-34[DOI][PubMed]
  • 7. Mahendran V, Tan YS, Riordan SM, Grimm MC, Day AS, Lemberg DA, et al. The prevalence and polymorphisms of zonula occluden toxin gene in multiple Campylobacter concisus strains isolated from saliva of patients with inflammatory bowel disease and controls. PLoS One. 2013; 8(9)[DOI][PubMed]
  • 8. Zhang L, Lee H, Grimm MC, Riordan SM, Day AS, Lemberg DA. Campylobacter concisus and inflammatory bowel disease. World J Gastroenterol. 2014; 20(5): 1259-67[DOI][PubMed]
  • 9. Chamberlin W, Borody TJ, Campbell J. Primary treatment of Crohn's disease: Combined antibiotics taking center stage. Expert Rev Clin Immunol. 2011; 7(6): 751-60[DOI][PubMed]
  • 10. Marks DJ, Harbord MW, MacAllister R, Rahman FZ, Young J, Al-Lazikani B, et al. Defective acute inflammation in Crohn's disease: a clinical investigation. Lancet. 2006; 367(9511): 668-78[DOI][PubMed]
  • 11. Smith AM, Rahman FZ, Hayee B, Graham SJ, Marks DJ, Sewell GW, et al. Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease. J Exp Med. 2009; 206(9): 1883-97[DOI][PubMed]
  • 12. Marks DJ. Defective innate immunity in inflammatory bowel disease: A Crohn's disease exclusivity? Curr Opin Gastroenterol. 2011; 27(4): 328-34[DOI][PubMed]
  • 13. Bystrom J, Thomson SJ, Johansson J, Edin ML, Zeldin DC, Gilroy DW, et al. Inducible CYP2J2 and its product 11,12-EET promotes bacterial phagocytosis: a role for CYP2J2 deficiency in the pathogenesis of Crohn's disease? PLoS One. 2013; 8(9)[DOI][PubMed]
  • 14. Henckaerts L, Vermeire S. NOD2/CARD15 disease associations other than Crohn's disease. Inflamm Bowel Dis. 2007; 13(2): 235-41[DOI][PubMed]
  • 15. Glocker E, Grimbacher B. Inflammatory bowel disease: Is it a primary immunodeficiency? Cell Mol Life Sci. 2012; 69(1): 41-8[DOI][PubMed]
  • 16. Actis GC, Pellicano R, Rosina F. Intrahepatic cholestasis in Bruton's agammaglobulinemia receiving mesalamine for co-morbid Crohn's disease. J Pharmacol Pharmacother. 2014; 5(2): 151-2[DOI][PubMed]
  • 17. Al-Absi AI, Cooke CR, Wall BM, Sylvestre P, Ismail MK, Mya M. Patterns of injury in mycophenolate mofetil-related colitis. Transplant Proc. 2010; 42(9): 3591-3[DOI][PubMed]
  • 18. Ardelean DS, Gonska T, Wires S, Cutz E, Griffiths A, Harvey E, et al. Severe ulcerative colitis after rituximab therapy. Pediatrics. 2010; 126(1)-6[DOI][PubMed]
  • 19. Actis GC, Lagget M, Pellicano R, Rosina F. Pancolitis during etanercept treatment of rheumatoid arthritis relapsing on the administration of further two TNF-alpha inhibitors. Int J Colorectal Dis. 2012; 27(4): 547-8[DOI][PubMed]
  • 20. Toussirot E, Houvenagel E, Goeb V, Fouache D, Martin A, Le Dantec P, et al. Development of inflammatory bowel disease during anti-TNF-alpha therapy for inflammatory rheumatic disease: A nationwide series. Joint Bone Spine. 2012; 79(5): 457-63[DOI][PubMed]
  • 21. Hvas CL, Kelsen J, Agnholt J, Dige A, Christensen LA, Dahlerup JF. Discrete changes in circulating regulatory T cells during infliximab treatment of Crohn's disease. Autoimmunity. 2010; 43(4): 325-33[DOI][PubMed]
  • 22. Shaw SY, Blanchard JF, Bernstein CN. Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease. Am J Gastroenterol. 2010; 105(12): 2687-92[DOI][PubMed]
  • 23. Nobel YR, Cox LM, Kirigin FF, Bokulich NA, Yamanishi S, Teitler I, et al. Metabolic and metagenomic outcomes from early-life pulsed antibiotic treatment. Nat Commun. 2015; 6: 7486[DOI][PubMed]
  • 24. Ananthakrishnan AN, Higuchi LM, Huang ES, Khalili H, Richter JM, Fuchs CS, et al. Aspirin, nonsteroidal anti-inflammatory drug use, and risk for Crohn disease and ulcerative colitis: A cohort study. Ann Intern Med. 2012; 156(5): 350-9[DOI][PubMed]
  • 25. Masclee GM, Coloma PM, Kuipers EJ, Sturkenboom MC. Increased risk of microscopic colitis with use of proton pump inhibitors and non-steroidal anti-inflammatory drugs. Am J Gastroenterol. 2015; 110(5): 749-59[DOI][PubMed]
  • 26. Parkes GC, Whelan K, Lindsay JO. Smoking in inflammatory bowel disease: impact on disease course and insights into the aetiology of its effect. J Crohns Colitis. 2014; 8(8): 717-25[DOI][PubMed]
  • 27. Bernstein CN, Singh S, Graff LA, Walker JR, Miller N, Cheang M. A prospective population-based study of triggers of symptomatic flares in IBD. Am J Gastroenterol. 2010; 105(9): 1994-2002[DOI][PubMed]
  • 28. Fuller-Thomson E, Lateef R, Sulman J. Robust Association Between Inflammatory Bowel Disease and Generalized Anxiety Disorder: Findings from a Nationally Representative Canadian Study. Inflamm Bowel Dis. 2015; 21(10): 2341-8[DOI][PubMed]
  • 29. Actis GC. The gut microbiome. Inflamm Allergy Drug Targets. 2014; 13(4): 217-23[PubMed]
  • 30. David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014; 505(7484): 559-63[DOI][PubMed]
  • 31. Buscarini E, Conte D, Cannizzaro R, Bazzoli F, De Boni M, Delle Fave G, et al. White paper of Italian Gastroenterology: delivery of services for digestive diseases in Italy: Weaknesses and strengths. Dig Liver Dis. 2014; 46(7): 579-89[DOI][PubMed]
  • 32. Ng SC. Emerging leadership lecture: Inflammatory bowel disease in Asia: emergence of a "Western" disease. J Gastroenterol Hepatol. 2015; 30(3): 440-5[DOI][PubMed]
  • 33. Benchimol EI, Mack DR, Guttmann A, Nguyen GC, To T, Mojaverian N, et al. Inflammatory bowel disease in immigrants to Canada and their children: a population-based cohort study. Am J Gastroenterol. 2015; 110(4): 553-63[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments